Determinants of successful chronic hepatitis C case finding among patients receiving opioid maintenance treatment in a primary care setting

Addiction

Volumn 104, Issue 12, 2009, Pages 2033-2038

  Senn, Oliver ^a   Seidenberg, André ^a,b   Rosemann, Thomas ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Private Practice   (Switzerland)

Author keywords

General practice; Hepatitis C; Methadone substitution; Opioid dependence; Primary care; Screening

Indexed keywords

BUPRENORPHINE; METHADONE; MORPHINE;

ADULT; ANTIBODY SCREENING; ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; GENERAL PRACTITIONER; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OPIATE ADDICTION; PRIMARY MEDICAL CARE; SEROLOGY; SWITZERLAND;

ADULT; ANALGESICS, OPIOID; BUPRENORPHINE; FAMILY PRACTICE; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; METHADONE; MORPHINE; NARCOTICS; POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; SWITZERLAND;

EID: 70449378943     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2009.02766.x     Document Type: Article

References (22)

1. Lim Y. S., Kim W. R. The global impact of hepatic fibrosis and end-stage liver disease. Clin Liver Dis 2008 12 : 733 746. vii.
2. Verna E. C., Brown R. S. Jr. Hepatitis C virus and liver transplantation. Clin Liver Dis 2006 10 : 919 940.
3. Marsch L. A. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction 1998 93 : 515 532.
4. Roux P., Carrieri M. P., Villes V., Dellamonica P., Poizot-Martin I., Ravaux I. et al. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study. Addiction 2008 103 : 1828 1836.
5. MacGowan R. J., Brackbill R. M., Rugg D. L., Swanson N. M., Weinstein B., Couchon A. et al. Sex, drugs and HIV counseling and testing: a prospective study of behavior-change among methadone-maintenance clients in New England. AIDS 1997 11 : 229 235.
6. Gourevitch M. N., Hartel D., Selwyn P. A., Schoenbaum E. E., Klein R. S. Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis. AIDS 1999 13 : 2069 2074.
7. Mauss S., Berger F., Goelz J., Jacob B., Schmutz G. A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance. Hepatology 2004 40 : 120 124.
8. Krook A. L., Stokka D., Heger B., Nygaard E. Hepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study. Eur Addict Res 2007 13 : 216 221.
9. Fried R., Monnat M., Seidenberg A., Oppliger R., Schmid P., Herold M. et al. Swiss multicenter study evaluating the efficacy, feasibility and safety of peginterferon-alfa-2a and ribavirin in patients with chronic hepatitis C in official opiate substitution programs. Digestion 2008 78 : 123 130.
10. Bruggmann P., Falcato L., Dober S., Helbling B., Keiser O., Negro F. et al. Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients. J Viral Hepatol 2008 15 : 747 752.
11. Klingemann H. K. Drug treatment in Switzerland: harm reduction, decentralization and community response. Addiction 1996 91 : 723 736.
12. Pelet A., Doll S., Huissoud T., Resplendino J., Besson J., Favrat B. Methadone maintenance treatment in the Swiss Canton of Vaud: demographic and clinical data on 1,782 ambulatory patients. Eur Addict Res 2005 11 : 99 106.
13. Pelet A., Doll S., Huissoud T., Resplendino J., Besson J., Favrat B. Methadone maintenance treatment (MMT) in general practice or in specialized centers: profile of patients in the Swiss Canton of Vaud. Am J Drug Alcohol Abuse 2007 33 : 665 674.
14. Litwin A. H., Kunins H. V., Berg K. M., Federman A. D., Heavner K. K., Gourevitch M. N. et al. Hepatitis C management by addiction medicine physicians: results from a national survey. J Subst Abuse Treat 2007 33 : 99 105.
15. Stoove M. A., Gifford S. M., Dore G. J. The impact of injecting drug use status on hepatitis C-related referral and treatment. Drug Alcohol Depend 2005 77 : 81 6.
16. Lewis D., Bellis M. General practice or drug clinic for methadone maintenance? A controlled comparison of treatment outcomes. Int J Drug Policy 2001 12 : 81 9.
17. Seidenberg A., Peng M., Custer R. Prinzipien der Sicheren Opioidverordnung. Bern : Bundesamt für Gesundheit 2002.
18. Kakko J., Gronbladh L., Svanborg K. D., von Wachenfeldt J., Ruck C., Rawlings B. et al. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. Am J Psychiatry 2007 164 : 797 803.
19. Dobler-Mikola A., Hattenschwiler J., Meili D., Beck T., Boni E., Modestin J. Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment. J Subst Abuse Treat 2005 29 : 259 265.
20. McGillion J., Wanigaratne S., Feinmann C., Godden T., Byrne A. GPs' attitudes towards the treatment of drug misusers. Br J Gen Pract 2000 50 : 385 386.
21. National Institutes of Health Consensus Development Conference Statement. Management of hepatitis C: 2002 - June 10-12, 2002. Hepatology 2002 36 : S3 20.
22. Broers B., Junet C., Bourquin M., Deglon J. J., Perrin L., Hirschel B. Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. AIDS 1998 12 : 2059 2066.